Antitumour Effects of Isocurcumenol Isolated from Curcuma zedoaria Rhizomes on Human and Murine Cancer Cells
Figure 8
AO/Et Br staining in DLA cells treated with isocurcumenol (a and b). Untreated and 50 μg/mL treated DLA cells (c and d). Untreated and 100 μg/mL treated KB cells (e and f). Untreated and 50 μg/mL treated A 549 cells (g and h). Untreated and 50 μg/mL treated K-562 cells. (i) Graph showing the % of apoptotic cells induced by treatment with isocurcumenol by AO/EtBr staining on cancer cell lines. () shows the apoptotic cells.
(a) Untreated DLA cells
(b) Treated DLA cells (50 μg/ml)
(c) Untreated KB cells
(d) Treated KB cells (100 μg/ml)
(e) Untreated A 549 cells
(f) Treated A 549 cells (50 μg/ml)
(g) Untreated K562 cells
(h) Treated K562 cells (50 μg/ml)
(i) Graph showing the % of apoptotic cells induced by the activecompound by AO/EtBr staining on cancer cell lines ()
